Selected highlights of the 2019 Pulmonary Pathology Society Biennial Meeting: PD-L1 test harmonization studies

Immune checkpoint inhibitors (ICI) including programmed death 1 (PD-1) inhibitors, such as nivolumab and pembrolizumab, or programmed death ligand 1 (PD-L1) inhibitors, such as atezolizumab and durvalumab, have recently emerged in advanced stage lung cancer as new standards of care. They are now ind...

Descripción completa

Detalles Bibliográficos
Autores principales: Lantuejoul, Sylvie, Damiola, Francesca, Adam, Julien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Review Article on Selected Highlights of the 2019 Pulmonary Pathology Society Biennial Meeting
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354161/
https://www.ncbi.nlm.nih.gov/pubmed/32676356
http://dx.doi.org/10.21037/tlcr.2020.03.23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354161/
https://www.ncbi.nlm.nih.gov/pubmed/32676356
http://dx.doi.org/10.21037/tlcr.2020.03.23

Ejemplares similares